
    
      Parents of newborns will be invited to test if their newborns are affected with ALD. The
      routine newborn screening dried blood spots sample will be used to test the concentration of
      C26:0-lyso-PC . If positive of a screening test, further confirmation tests including
      physical examination and other methodology for ALD confirmation will be provided. Genetic
      counseling and treatment option will be provided, too.
    
  